Citations for
1ARRDC3, ELP3, GATA5
Promoter hypermethylation may be an important mechanism of the transcriptional inactivation of ARRDC3, GATA5, and ELP3 in invasive ductal breast carcinoma.
Wang D, Yang PN, Chen J, Zhou XY, Liu QJ, Li HJ, Li CL.
Mol Cell Biochem 396(1-2):67-77. doi: 10.1007/s11010-014-2143-y. 2014
2ARRDC3, NEDD4
Arrestin domain-containing protein 3 recruits the NEDD4 E3 ligase to mediate ubiquitination of the beta2-adrenergic receptor.
Nabhan JF, Pan H, Lu Q.
EMBO Rep 11(8):605-11. Epub 2010 Jun 18.PMID: 20559325 2010
3ARRDC3, ITGB4
ARRDC3 suppresses breast cancer progression by negatively regulating integrin beta4.
Draheim KM, Chen HB, Tao Q, Moore N, Roche M, Lyle S.
Oncogene 29(36):5032-47. Epub 2010 Jul 5. 2010
4ARRDC3
Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins.
Patwari P, Chutkow WA, Cummings K, Verstraeten VL, Lammerding J, Schreiter ER, Lee RT.
J Biol Chem 284(37):24996-5003. Epub 2009 Jul 15. 2009
5ARRDC3
Thioredoxin-binding protein-2-like inducible membrane protein is a novel vitamin D3 and peroxisome proliferator-activated receptor (PPAR)gamma ligand target protein that regulates PPARgamma signaling.
Oka S, Masutani H, Liu W, Horita H, Wang D, Kizaka-Kondoh S, Yodoi J.
Endocrinology 147(2):733-43. Epub 2005 Nov 3. 2006